Wednesday, January 27, 2021

Covid-19 Vaccine Update: First Batch Of Russia ‘Sputnik V’ Expected To Reach Kanpur Next Week For Phase 2, 3 Clinical Trials

Must Read

Cathy Wood: Bitcoin ETF Approval Impossible Market Cap Rises Around $ 2T – Coindesk

Kathy Wood, chief executive of Orc Investment Management, said he doubted U.S. regulators would give the green light...

Blockchain bites: Universities gain bitcoin exposure as institutional ETH appetite increases – Coindesk

Three storiesLooking for overstock Exit its blockchain related investments, Reported by Tanjil Akhtar of Koindesk. The online...

Senate approves Janet Yellen as US Treasury Secretary

Janet Yellen is the US 78th U.S. Secretary of the Treasury.The former Federal Reserve chair and longtime economist...


Coronavirus Vaccine ‘Sputnik V’ developed by Russia is expected to arrive Ganesh Shankar Vidyarthi Medical College in Kanpur by next week for the second and third phase of vaccine’s human clinical trials. ALSO READ | Dr Reddy’s Gets DCGI Nod To Conduct Stage 2/3 Human Trials For Russia’s Sputnik V Covid-19 Vaccine

Sputnik V is an adenovirus vector-based vaccine, which was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on August 11. In September 2020, Dr. Reddy’s Lab and RDIF entered into a partnership to conduct clinical trials and distribute the vaccine in the country. As part of the agreement, the RDIF will supply 100 million doses of the Vaccine to the country upon approval.

After approval from the Drug Controller General of India (DCGI), the pharma giant Dr Reddy’s Laboratories is set to test the Russian Sputnik V vaccine against Covid-19 on 100 volunteers in India. Once the testing is complete and the vaccine is approved, the RDIF will be referring 100 million doses of Sputnik V to Dr. Reddy’s lab.

According to a Sputnik news report, Gamaleya National Research Center director Alexander Gintsburghas claimed that vaccine used inanimate particles created on the basis of adenovirus. He considered said that there are no concerns the vaccine could cause any harm to a person’s health.

ALSO READ | Sputnik V: From Human Trials To Production, 5 Things To Know About Covid-19 Vaccine Made By Russia

In Russia around 40,000 subjects are going through phase three clinical trials of the Sputnik V vaccine and the UAE also started the phase 3 clinical trials of the vaccine last week.

Russia has named its first COVID-19 vaccine Sputnik V after its Soviet-era satellite, that was the first one from the globe to get launched into space. Naming it after its satellite, Moscow has tend to showcase its success at becoming the first country to develop the vaccine for Coronavirus which has already killed almost 20 million people across the globe.

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Cathy Wood: Bitcoin ETF Approval Impossible Market Cap Rises Around $ 2T – Coindesk

Kathy Wood, chief executive of Orc Investment Management, said he doubted U.S. regulators would give the green light...

Blockchain bites: Universities gain bitcoin exposure as institutional ETH appetite increases – Coindesk

Three storiesLooking for overstock Exit its blockchain related investments, Reported by Tanjil Akhtar of Koindesk. The online shopping giant that crypto-hype has...

Senate approves Janet Yellen as US Treasury Secretary

Janet Yellen is the US 78th U.S. Secretary of the Treasury.The former Federal Reserve chair and longtime economist received enough votes in the...

Marcelo Prates – The Future of Money in Multiverse – Koindesk

The year is 2026. Although no new coronavirus form has become epidemic since 2025, the three passengers on board the plane in...

Ethereum’s Ether cryptocurrency sets new all-time high above All 1,450 – Coindesk

The price of the native cryptocurrency ether (ETH) of the Ethereum blockchain network reached record levels on Sunday.

More Articles Like This